ResMed Inc (STU:RME)
€ 232.3 -1.9 (-0.81%) Market Cap: 34.52 Bil Enterprise Value: 34.92 Bil PE Ratio: 32.70 PB Ratio: 6.98 GF Score: 98/100

Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 14, 2022 / 08:05AM GMT
Release Date Price: €233.15
Lyanne Harrison
BofA Securities, Research Division - VP in Global Equity Research

Mick, thank you so much for coming to our conference.

Michael J. Farrell
ResMed Inc. - CEO & Director

Happy to be here, Lyanne. Thank you for hosting us.

Questions & Answers

Lyanne Harrison
BofA Securities, Research Division - VP in Global Equity Research

So it's been a very interesting few years for ResMed. And so why don't we start with, obviously, the COVID disruption and the likes there. What's -- obviously, some challenges because of COVID, but what's come out of COVID that's been a positive, both for ResMed and the industry?

Michael J. Farrell
ResMed Inc. - CEO & Director

I mean huge implications for the whole world through the COVID-19 pandemic and the recovery. I think for us, I mean, obviously, the challenges we face, the same challenges as everyone did, which is shut down, go fully remote for parts of the business that weren't manufacturing, tech service,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot